R(+)-pulegone impairs Ca2+ homeostasis and causes negative inotropism in mammalian myocardium

被引:22
作者
de Cerqueira, Sandra Valeria Santos [1 ]
Santana Gondim, Antonio Nei [2 ,3 ]
Roman-Campos, Danilo [2 ]
Cruz, Jader Santos [2 ]
da Silva Passos, Amilton Gustavo [1 ]
Lauton-Santos, Sandra [1 ]
Lara, Aline [4 ]
Guatimosim, Silvia [4 ]
Conde-Garcia, Eduardo Antonio [1 ]
de Oliveira, Evaleide Diniz [1 ]
Lins de Vasconcelos, Carla Maria [1 ]
机构
[1] Univ Fed Sergipe, Dept Fisiol, Lab Biofis Coracao, Aracaju, SE, Brazil
[2] Univ Fed Minas Gerais, Dept Imunol & Bioquim, Dept Membranas Excitaveis, Belo Horizonte, MG, Brazil
[3] Univ Estado Bahia, Dept Educ, Lab Biofis & Farmacol Coracao, Guanambi, BA, Brazil
[4] Univ Fed Minas Gerais, Dept Fisiol & Biofis, Lab Sinalizacao Intracelular Cardiomiocito, Belo Horizonte, MG, Brazil
关键词
R(+)-pulegone; Contractility; L-type calcium current; Calcium transient; Cardiac action potential; Potassium current; GUINEA-PIG; PENNYROYAL OIL; CARDIAC MYOCYTES; SMOOTH-MUSCLE; RELAXATION; RATS; HEPATOTOXICITY; RABBIT; MOUSE; CELLS;
D O I
10.1016/j.ejphar.2011.09.186
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study aimed to investigate the inotropic effects of R(+)-pulegone, a monoterpene found in plant species belonging to the genus Mentha, on the mammalian heart. In electrically stimulated guinea pig atria, R(+)-pulegone reduced the contractile force (similar to 83%) and decreased the contraction time measured at 50% of the maximum force amplitude (CT50) from 45.8 +/- 6.2 ms to 36.9 +/- 6.2 ms, suggesting that R(+)-pulegone may have an effect on Ca2+ homeostasis. Nifedipine (40 mu m), taken as a positive control, showed a very similar profile. To explore the hypothesis that R(+)-pulegone is somehow affecting Ca2+ handling, we determined concentration-response curves for both CaCl2 and BAY K8644. R(+)-pulegone shifted these curves rightward. Using isolated mouse ventricular cardiomyocytes, we measured whole-cell L-type Ca2+ current and observed an I-Ca,I-L peak reduction of 13.7 +/- 2.5% and 40.2 +/- 2.9% after a 3-min perfusion with 0.11 and 1.1 mM of R(+)-pulegone, respectively. In addition, the intracellular Ca2+ transient was decreased (72.9%) by 3.2 mM R(+)-pulegone, with no significant changes in [Ca2+](i) transient decay kinetics. Moreover, R(+)-pulegone at 1.1 mM prolonged the action potential duration at 10, 50, and 90% of repolarisation. The lengthening of the action potential duration may be attributed to the substantial blockade of the outward K+ currents caused by 1.1 mM of R(+)-pulegone (90.5% at 60 mV). These findings suggest that R(+)-pulegone exerts its negative inotropic effect on mammalian heart mainly by decreasing the L-type Ca2+ current and the global intracellular Ca2+ transient. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 37 条
[1]   Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature [J].
Anderson, IB ;
Mullen, WH ;
Meeker, JE ;
KhojastehBakht, SC ;
Oishi, S ;
Nelson, SD ;
Blanc, PD .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (08) :726-+
[2]  
Bakerink JA, 1996, PEDIATRICS, V98, P944
[3]   RELAXATION IN RABBIT AND RAT CARDIAC-CELLS - SPECIES-DEPENDENT DIFFERENCES IN CELLULAR MECHANISMS [J].
BASSANI, JWM ;
BASSANI, RA ;
BERS, DM .
JOURNAL OF PHYSIOLOGY-LONDON, 1994, 476 (02) :279-293
[4]   Action potential duration determines sarcoplasmic reticulum Ca2+ reloading in mammalian ventricular myocytes [J].
Bassani, RA ;
Altamirano, J ;
Puglisi, JL ;
Bers, DM .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 559 (02) :593-609
[5]   Pharmacologic evaluation of isometric contraction-relaxation coupling indexes in rabbit ventricular muscle [J].
Baudet, S ;
Noireaud, J .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1999, 42 (01) :21-30
[6]   Cardiac excitation-contraction coupling [J].
Bers, DM .
NATURE, 2002, 415 (6868) :198-205
[7]  
BERS DM, 2001, HEART PHYSL PATHOPHY, P779
[8]   Calcium cycling and signaling in cardiac myocytes [J].
Bers, Donald M. .
ANNUAL REVIEW OF PHYSIOLOGY, 2008, 70 :23-49
[9]  
BOWEN IH, 1992, ADVERSE EFFECTS HERB, V1, P171
[10]  
Brankovic SV, 2009, GEN PHYSIOL BIOPHYS, V28, P174